Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 3.2% on an annualized basis producing an average annual return of 14.24%. Currently, Novo Nordisk has a market capitalization of $392.68 billion.
Buying $1000 In NVO: If …
Full story available on Benzinga.com
Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 3.2% on an annualized basis producing an average annual return of 14.24%. Currently, Novo Nordisk has a market capitalization of $392.68 billion.
Buying $1000 In NVO: If …
Full story available on Benzinga.com
Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 3.2% on an annualized basis producing an average annual return of 14.24%. Currently, Novo Nordisk has a market capitalization of $392.68 billion.
Buying $1000 In NVO: If …Full story available on Benzinga.com Read MoreBZI-POD, News, NVO, Trading Ideas, NVO, US6701002056, News, Trading Ideas, Benzinga News
